Myricetin loaded in solid lipid nanoparticles induces apoptosis in the HT-29 colorectal cancer cells via mitochondrial dysfunction

[1]  Swati G. Patel,et al.  The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. , 2022, The lancet. Gastroenterology & hepatology.

[2]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  N. Jha,et al.  Oxidative Stress in Cancer Cell Metabolism , 2021, Antioxidants.

[4]  M. Soleimani,et al.  Myricetin Exerts its Apoptotic Effects on MCF-7 Breast Cancer Cells through Evoking the BRCA1-GADD45 Pathway , 2020, Asian Pacific journal of cancer prevention : APJCP.

[5]  Sebastián Scioli Montoto,et al.  Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects , 2020, Frontiers in Molecular Biosciences.

[6]  D. Kweon,et al.  Reduction of focal sweating by lipid nanoparticle-delivered myricetin , 2020, Scientific Reports.

[7]  B. Salehi,et al.  Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications , 2020, BMC Complementary Medicine and Therapies.

[8]  Shu-wen Yu,et al.  Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells , 2020, BMC Complementary Medicine and Therapies.

[9]  A. Osman,et al.  5-Fluorouracil and Simvastatin Loaded Solid Lipid Nanoparticles for Effective Treatment of Colorectal Cancer Cells , 2020 .

[10]  N. Chudapongse,et al.  Development of Lipid-Based Nanocarriers for Increasing Gastrointestinal Absorption of Lupinifolin , 2020, Planta Medica.

[11]  L. Khorsandi,et al.  Myricetin Loaded Solid Lipid Nanoparticles Upregulate MLKL and RIPK3 in Human Lung Adenocarcinoma , 2019, International Journal of Peptide Research and Therapeutics.

[12]  I. Alkorta,et al.  Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs , 2019, Nanomaterials.

[13]  Prashanth Rawla,et al.  Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors , 2019, Przeglad gastroenterologiczny.

[14]  F. Bazer,et al.  Myricetin treatment induces apoptosis in canine osteosarcoma cells by inducing DNA fragmentation, disrupting redox homeostasis, and mediating loss of mitochondrial membrane potential , 2018, Journal of cellular physiology.

[15]  H. Rupasinghe,et al.  Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  Yinghao Sun,et al.  The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction , 2018, Cellular Physiology and Biochemistry.

[17]  Y. Choi,et al.  Potential role of nucleoside diphosphate kinase in myricetin-induced selective apoptosis in colon cancer HCT-15 cells. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[18]  S. Serini,et al.  Omega-3 PUFA Loaded in Resveratrol-Based Solid Lipid Nanoparticles: Physicochemical Properties and Antineoplastic Activities in Human Colorectal Cancer Cells In Vitro , 2018, International journal of molecular sciences.

[19]  N. Nafee,et al.  Myricetin solid lipid nanoparticles: Stability assurance from system preparation to site of action , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[20]  Satheesh Natarajan,et al.  Papain Loaded Solid Lipid Nanoparticles for Colorectal Cancer Therapy , 2017 .

[21]  Jun Sik Lee,et al.  Anti-cancer activity of myricetin against human papillary thyroid cancer cells involves mitochondrial dysfunction-mediated apoptosis. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  G. Wang,et al.  In vitro and in vivo evaluation of functionalized chitosan-Pluronic micelles loaded with myricetin on glioblastoma cancer. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[23]  D. Trisciuoglio,et al.  Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies , 2016, Aging.

[24]  Jun-Xia Chen,et al.  Myricetin exhibits anti-glioma potential by inducing mitochondrial-mediated apoptosis, cell cycle arrest, inhibition of cell migration and ROS generation. , 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[25]  Chenming Zhang,et al.  Natural product-based nanomedicine: recent advances and issues , 2015, International journal of nanomedicine.

[26]  Jun Sik Lee,et al.  Myricetin induces cell death of human colon cancer cells via BAX/BCL2-dependent pathway. , 2014, Anticancer research.

[27]  Yingzhuo Shen,et al.  Myricetin induces apoptosis in HepG2 cells through Akt/p70S6K/bad signaling and mitochondrial apoptotic pathway. , 2013, Anti-cancer agents in medicinal chemistry.

[28]  R. Deng,et al.  Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: Hirsutanol A inhibits tumor growth through ROS production , 2013, Journal of Translational Medicine.

[29]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.